Not Yet RecruitingNot Applicable

Individual Risk Profiles for Adverse Drug Reactions in Geriatric Patients

2,000 participantsStarted 2022-07

Plain-language summary

This project will generate a prospective cohort of geriatric patients with polypharmacy which will be characterized for vulnerability profiles of adverse drug reactions.

Who can participate

Age range

70 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 70 years or older * Current drug therapy with three or more drugs * Being a patient in the interdisciplinary polypharmacy consultation service of the geriatric university outpatient clinic * Sufficient mobility (minimum: Wheelchair mobility) * Written informed consent of the patient or the legal representative Exclusion Criteria: * No sufficient communication possible * Patients classified as terminally ill by the medical staff * Patients, that are incapable to give their informed consent and who do not have a legal representative

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Identification of vulnerability profiles of adverse drug reactions

Timeframe: February 2022 - February 2032

Trial details

NCT IDNCT05247814

SponsorRWTH Aachen University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2032-02

Contact for this trial

Mathias Freitag

+492417501116 mfreitag@ukaachen.de

View on ClinicalTrials.gov More Polypharmacy trials

Who can participate

Age range

70 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.